GoodRx Holdings (GDRX) Change in Receivables (2019 - 2026)

GoodRx Holdings' Change in Receivables history runs 8 years deep, the most recent figure standing at -$3.0 million for Q1 2026.

• In Q1 2026, Change in Receivables fell 121.33% year-over-year to -$3.0 million; the TTM figure through Mar 2026 stood at $70.8 million (up 361.35% YoY), while the FY2025 annual figure was $88.0 million, up 3684.01% from the prior year.
• Change in Receivables came in at -$3.0 million for Q1 2026 at GoodRx Holdings, down from $30.2 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $30.2 million in Q4 2025 to a low of -$31.0 million in Q3 2024.
• A 5-year average of $6.6 million and a median of $5.2 million in 2022 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables slumped 1287.59% in 2024 and jumped 1121.62% in 2025, its largest moves.
• GoodRx Holdings' Change in Receivables stood at -$3.7 million in 2022, then surged by 699.79% to $22.5 million in 2023, then plunged by 32.64% to $15.1 million in 2024, then soared by 99.67% to $30.2 million in 2025, then plunged by 110.01% to -$3.0 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered -$3.0 million, $30.2 million, and $14.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison